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Executive Summary/Abstract 
BACKGROUND 
Drug abusers are generally more involved in crime, in particular property crime, 
than people who are not drug abusers. Substitution programs have been developed 
in order to improve drug users’ quality of life and to decrease their criminal 
involvement. Several evaluations, but not all, have reported crime reductions 
following substitution therapies based on heroin and methadone prescription.  
 
OBJECTIVES 
This systematic review is aimed at gaining an overall picture on the respective effects 
of prescription of methadone vs. heroin and other substances.   
Search strategy: Six databases (Medline, Campbell Crime and Justice Group, 
National Criminal Justice Reference Service, National Treatment Agency for 
Substance Misuse, JSTOR and Criminal Justice Abstracts) as well as relevant 
journals and websites (Harm reduction Journal, Journal of Substance Abuse 
Treatment, Drug and Alcohol Dependence, Drug and Alcohol Review, Drug and 
Therapeutics Bulletin, International Journal of Drug Policy, Journal of Clinical 
Psychopharmacology, Déviance et Société, Criminal Justice and Behavior, 
Criminologie, www.heroinstudie.de and www.drugscope.org.uk) have been searched 
for relevant studies meeting the inclusion criteria.  
 
SELECTION CRITERIA 
To be eligible, studies had to assess the effects of any substitution therapy (using e.g. 
methadone and/or opiates as substitution drugs). Only effects on offending have 
been considered. Comparisons of competing treatments (substitution therapy vs. 
any other form of treatment, including placebo treatment or no treatment at all) 
were restricted to studies meeting level 4 or higher on the scale developed by 
Sherman et al. (1997). In addition, one-group pre-post evaluations of substitution 
therapies were included because changes in offending are substantial compared to 
pre-treatment levels, while comparisons of treatment with several substances often 
show modest differences. Finally, studies that assessed the impact of drug 
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substitution at the macro (i.e. city or regional) level were also included. The three 
different types of studies have been analyzed separately.  
 
DATA COLLECTION AND ANALYSIS 
66 studies were considered, and 46 were selected for inclusion in the review. They 
separately assess the impact of methadone, buprenorphine, heroin, naltrexone, 
dihydrocodeine or Levo-alpha-acetylmethadone substitution on the criminal 
behaviour of opiates addicts. Meta-analytic techniques were used to identify overall 
effects of several substances. Comparisons of different treatments (i.e. substitution 
vs. any other treatment) were restricted to studies meeting levels 4 or 5 on the scale 
developed by Sherman et al. (1997).  
 
MAIN RESULTS 
Heroin maintenance reduces crime significantly more than Methadone 
maintenance. Methadone maintenance reduces offending more than treatments 
without substitution therapy, but the mean effect size is not significant (p >.1). 
However, very large (and significant) reductions in criminal behaviour are observed 
during methadone maintenance therapy with respect to pre-treatment levels. 
Buprenorphine does not significantly reduce criminal behaviour, although effects 
are positive, be it with respect to methadone or a placebo. Naltrexone treatment 
reduces criminality significantly more than behaviour therapy or counselling.  
 
CONCLUSION 
Heroin maintenance has been found to significantly reduce criminal involvement 
among treated subjects, and it is more effective in crime reduction than methadone 
maintenance. Methadone maintenance greatly reduces criminal involvement, but 
apparently not significantly more so than other interventions. Buprenorphine and 
Naltrexone have been found to be promising, although few studies have been 
identified using these substances in maintenance treatment. 
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1 Background of the Review 
For the last decades, drug addiction has become an increasingly worrying problem 
throughout the Western World. Drug-addicts have been disproportionately involved 
in criminal activities, making drug-addiction, beyond public health concerns, a 
formidable challenge to public order. In 8 European countries, burglaries, robberies 
and other serious crimes increased by several hundred percent between 1970 and 
2000 (Killias, 2002, p.115). Comparison of self-reported delinquency in 7 countries 
(Killias & Ribeaud 1999) suggest that the extent of involvement in property crime 
among addicts of any kind of hard drugs is about 10 times higher than among non-
users. Thus, the increasing trends of robbery and burglary in many Western 
countries between 1970 and 1995 may reasonably also be seen as a side-effect of 
increasing drug use.  
 
In response to this phenomenon, numerous programs have been set up to provide 
drug addicts with narcotics (e.g., heroin prescription programs) and substitution 
drugs. The intended goals of such treatments have been:  
 
(1) to improve drug users’ quality of life, reducing the risks of overdose or 
contagious diseases, controlling the quality of drugs available on local 
markets, preventing marginalization and improving social integration,   
(2) to diminish social costs of drug addiction, 
(3) to reduce drug-related offences and protect public order. It is assumed 
that drug addicts commit many predatory offences mainly to finance the 
purchase of drugs, and that criminality will decrease once drugs are 
supplied to addicts through official channels. The same effect should be 
observed if drug addicts are supplied with products (such as methadone) 
that suppress physical effects of withdrawal and, indirectly, the 
immediate need to consume drugs,  
(4) to reduce public order problems of all sorts. If addicts obtain drugs 
through official channels, they should spend less time in the search for 
drugs, which means that they have more time available for legitimate 
earnings and will less concentrate in places where addicts and dealers 
regularly gather (e.g., “needle” parks in Switzerland).  
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Many researchers have studied the effects of drug prescription programs on criminal 
behaviour among participants. We shall review these programs and try to find out 
whether they have been effective in reducing criminality.  
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2 Objectives of the Review 
The review aims at evaluating the effects of drug prescription and substitution 
programs on criminal behaviour among participants. To be included in this review, 
studies have to assess the effects of drug substitution on offending. If this review 
reveals significant effects of such programs on criminality, the results could have 
implications for crime and justice as well as for drug policies. For example, if the 
results of our meta-analysis support the conclusion that heroin maintenance reduces 
criminality, medical prescription of heroin could be an option in the treatment of 
severely addicted drug users with high criminal involvement whenever reductions in 
offending is among the priorities.  
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3 Methods 
3.1  SEARCH STRATEGY FOR IDENTIFICATION OF 
RELEVANT STUDIES  
Relevant studies have been identified through abstracts, bibliographies and 
databases such as Campbell Crime and Justice Group (C2-SPECTR), National 
Criminal Justice Reference Service (NCJRS), Medline, Harm Reduction Journal, 
Journal of Substance Abuse Treatment, National Treatment Agency for Substance 
Misuse (NHS), National Treatment Outcome Research Study (NTORS), Drug and 
Alcohol Dependence, Drug and Alcohol Review, Drug and Therapeutics Bulletin 
from the BMJ group (DTB), International Journal of Drug Policy, Central 
Committee on the Treatment of Heroin Addicts (CCBA), Journal of Clinical 
Psychopharmacology, Criminal Justice Abstracts (CJA), Déviance et Société, JSTOR, 
Criminal Justice and Behavior (CJB), Criminologie, the German literature 
(Heroinstudie.de-www.heroinstudie.de/H-Report P2 engl.pdf) and 
www.drugscope.org.uk. 
 
Furthermore, the bibliographies of relevant reviews (Amato et al., 2005; Farrell et 
al., 1994; Ferri, 2005; Hall, 1998; Holloway, 2005; Kosten et al., 1993; Luty, 2003; 
Prendergast, 2002) have been consulted. 
 
The keywords that have guided the search for references in databases and 
bibliographies were the following: drug addiction; drug prescription; substitution 
programs; controlled trial; re-offending; heroin; methadone; opiates, treatment 
programs; drug abuse; drug addict, heroin prescription, property crime, cocaine 
abuse; dexamphetamine; cocaine substitution. In addition, the following 
combinations of keywords have been used: substitution program + re-offending; 
heroin + treatment programs; heroin + substitution program; heroin + methadone; 
opiates + treatment; opiates + substitution; heroin + property crime; substitution 
programs + property crime, cocaine abuse + dexamphetamine.  
 
Being that the staff of the University of Zurich Institute for Criminology and 
Criminal Law is multi-lingual, studies published in any of the following languages 
were eligible for inclusion: English, French, German, Dutch, Italian, Spanish, 
Portuguese, Romanian, Polish, Ukrainian and Russian. In the protocol, it was 
foreseen that contacts would be established through international channels, such as 
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the European Sourcebook Group (with its network of correspondents in more than 
40 countries), the European Society of Criminology and the International Society of 
Criminology, with countries not routinely covered in international reviews of 
research. No relevant studies were identified through these channels, however. 
Studies published in any language after 1960 have been considered. 
 
3.2  CRITERIA FOR INCLUSION AND EXCLUSION OF 
STUDIES IN THE REVIEW 
Randomized studies, quasi-experimental studies and before-after comparisons on 
the effects on offending of drug substitution programs have been included. 
Interventions can be court-ordered or unrelated to any involvement of the criminal 
justice system. Only interventions based on substitution programs (using e.g. 
methadone and/or opiates as substitution drugs) will be considered. Possible effects 
beyond offending have not been considered, in particular eventual medical 
outcomes. A coding protocol was prepared along the guidelines of the Campbell 
Collaboration. Moreover, our review complies with the current standards of meta-
analysis (e.g. as specified in Practical Meta-Analysis by Lipsey & Wilson).  
 
3.3  TYPES OF STUDIES 
Studies meeting level 4 or higher on the scale developed by Sherman et al. (1997) 
have been considered for comparing competing treatments. In addition and in order 
to give the reader the full picture, pre-post studies have been included and mean 
effect sizes have been computed. Such studies are useful in the present context 
because changes in offending are often substantial compared to pre-treatment 
levels, while comparisons of treatment with several substances often show modest 
differences. 
 
Thus, the following types of studies have been included:  
(1) One-group, pre/post studies: studies comparing individual delinquency 
rates before, during and following treatment. To be eligible, studies had 
to include the prescription of a drug (e.g., methadone, heroin). 
(2) Multi-group comparison studies, including both true experimental 
studies (randomized designs) and quasi-experimental designs: studies 
comparing delinquency rates among subjects of an experimental group 
before, during and following treatment to those of a control group (with 
or without random assignment). As in the previous paragraph, studies 
were eligible only if the treatment group underwent substitution therapy. 
As a control group, we considered any group undergoing an alternative 
treatment or no treatment at all (including placebo control). For 
example, if the treatment group was treated with heroin as a substitution 
drug, the control group could remain untreated or may have received any 
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other substance as a substitution drug (e.g., methadone). It may also 
have undergone abstinence therapy with or without psychotherapy, 
detoxification, etc. 
(3) Macro level studies: studies assessing the impact of drug substitution at 
the macro (i.e. city, regional) level. In order to be eligible, such studies 
needed to measure the impact of the program on delinquency at the 
city/regional level, using police, court or survey data.  
 
The three different types of studies have been analyzed separately. All of the studies 
taken into account assess the effects of drug substitution programs on offending. 
 
The inclusion criteria have been restrained with respect to the protocol due to the 
large number of studies of levels 2 and 3. Whereas pre-post studies have been 
summarized below (Table 5), studies of level 3 have been dropped since a sufficient 
number of high-quality group comparisons (levels 4 and 5) have been identified 
(Tables 1, 2, 3 and 6). 
 
3.4  TYPES OF PROGRAMS 
3.4.1 Type of intervention  
Studies reporting effects of drug prescription and drug substitution programs on 
criminality among drug users have been included. By drug substitution program we 
understand programs that include the prescription of substances rather than 
programs based on drug abstinence. Methadone detoxification has not been 
considered as a substitution program, since the finality is abstinence and doses of 
methadone are reduced to zero after a relatively short period. The prescription must 
imply substances considered as substitutes for illegal drugs, for example, methadone 
or buprenorphine as a substitute of heroin. This excludes the prescription of drugs 
such as tranquillizers or antibiotics, frequently prescribed to drug users. However, 
studies using Naltrexone®, an opioid antagonist, have been included as well. The 
medically assisted prescription of heroin has also been included. This does not mean 
that heroin is a substitute of heroin, but that the uncontrolled consumption of 
heroin in the streets is replaced by the prescription of a controlled dosage of heroin, 
adapted to the user’s needs.  
 
Programs that do not include prescription of any substance have not been 
considered, such as programs based exclusively on, for example, psychotherapy, 
detoxification, etc, except in control groups where the treatment group underwent a 
substitution intervention. Only interventions based on substitution therapy (using 
e.g. methadone and/or opiates as substitution drugs) have been considered. 
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3.4.2 Kinds of drugs to be substituted by programs 
All drugs that are illegal according to international agreements and local (national) 
laws, such as heroin, morphine, opium, cocaine, crack, ecstasy, amphetamine, LSD, 
ketamine, cannabis, fentanyl, inhalants etc.  
3.4.3 Context of programs  
Any program, no matter whether treatment is court-ordered or unrelated to any 
involvement of the criminal justice system. Programs involving incarcerated drug-
addicts have not been considered since re-offending cannot be adequately tested as 
long as offenders remain in prison. Studies where treatment commences in prison 
but re-offending is measured after release have been included. 
 
3.5  TYPES OF OUTCOME MEASURES 
The key outcome measure considered is offending as measured by reconviction data, 
police records and studies on self-reported delinquency. Drug possession and 
consumption has not been considered expressly as a measure of offending although 
it is an offence in most countries. Since in many studies the overall number of 
crimes (as measured by self reports, arrests, convictions or incarcerations) is 
reported, drug possession and consumption is certainly included in some of these 
general outcome measures. To the extent that studies address the effects at the 
macro level, any conventional outcome measures (statistics, crime victim surveys 
etc.) have been considered. 
 
To assess improvement at the individual level, prevalence rates (or percentage of 
people who re-offend) as well as incidence rates (or number of offences committed 
per person) during standardized pre- and post-intervention periods have been 
considered. Prevalence rates inform on how many persons are diverted from 
criminal activity by prescription of substitution products, whereas incidence rates 
allow assessing whether fewer offences are committed as a result of the program. It 
is important to make this distinction since a given program may reduce the number 
of offences without affecting the number of offenders.  
Possible treatment effects beyond offending, such as medical outcomes or effects of 
such programs on drug markets have not been considered.  
 
3.6  TYPES OF PARTICIPANTS  
The considered population consists of drug-addicts (e.g. heroin addicts, cocaine 
addicts), adults and adolescents, males and females.  
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3.7  DESCRIPTION OF METHODS USED IN THE 
COMPONENT STUDIES 
The methods used by the studies covered by this review can be the following ones: 
Randomized studies, quasi-experimental studies and before-after comparisons.  
 
All studies included in this review will have a measure of the effects of drug 
substitution treatments on offending such as arrest, conviction, incarceration or self-
reports. 
 
3.8  CRITERIA FOR DETERMINATION OF INDEPENDENT 
FINDINGS 
There are three potential sources of non-independence of findings. We shall use the 
same criteria as in similar Campbell Review Protocols (e.g. Lipsey and Landenberger 
(2006); Wilson et al.(2007)).  
 
The first potential source of non-independence of findings is multiple indicators of 
offending reported from a single study (e.g. arrest, conviction). When more than one 
such outcome is reported, only one will be selected for the analysis. To maintain as 
much comparability as possible across studies, coders have selected the outcome 
measure that is most frequently represented in other studies in the collection 
(Lipsey et al., 2006). This has been “all offences”, measured usually at the level of 
arrests or self-reports. If “all offences” was not available, any among several 
outcomes was selected randomly. 
 
The second occurs when the same outcome is measured at multiple points in time, 
e.g., 6-months, 12-months, 18-months and two years post-treatment. In those cases, 
the measure with the timing closest to that most commonly used across all the 
studies (12 months) has been chosen to maximize comparability between studies 
(Lipsey et al., 2006).  
 
Finally, the third source of non-independent findings is the same data being 
reported across multiple documents. We have used author’s names, court location 
and study time frames as well as sample descriptions to identify multiple 
publications of the same evaluation. When such multiple publications were 
identified, the most complete and detailed manuscript was designated as the 
primary coding source. Additional manuscripts have been consulted to elaborate 
coding if necessary (Wilson et al., 2007). 
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3.9  DETAILS OF STUDY CODING CATEGORIES  
A coding protocol was developed for this synthesis that provides for a systematic 
method of extracting information regarding each study’s research design, program, 
nature of the outcome measure, and outcome data (see appendix- Coding Protocol).  
 
3.10  STATISTICAL PROCEDURES AND CONVENTIONS 
Our review complies with the current standards of meta-analysis (e.g. as specified in 
Practical Meta-Analysis by Lipsey & Wilson).  
 
The three types of studies mentioned above (pre/post studies, randomized 
controlled trials and quasi-experimental designs, and macro-level studies) have been 
synthesized and meta-analyzed separately.  
 
The effect of drug prescription or substitution programs on criminal behaviour was 
encoded using the odds-ratio. The odds-ratio is well suited to dichotomous 
outcomes, such as those commonly used in drug treatment. When offending was 
measured (quasi-) continuously (crime days, number of arrests), a standardized 
mean difference type effect size was computed and transformed into an odds-ratio 
(see Lipsey & Wilson, 2001). For pre-post studies, odds ratios have been computed 
between t0 and t1. An odds ratio of >1.0 indicates that treatment reduced offending, 
and an odds ratio of <1.0 was used whenever treatment was unsuccessful. Effect size 
outliers (›± 3.0 standard deviations) would have been winsorized to less extreme 
values (next highest not judged an outlier); however, no such outliers were observed. 
In addition, no data were imputed for missing values.   
 
For the computation of mean-effect sizes, the inverse variance method of meta-
analysis (Lipsey & Wilson, 2001) was used. In the first place, fixed-effect models 
were fitted. Whenever the Q-test refuted homogeneity, a random effects model was 
adopted.  
 
3.11  TREATMENT OF QUALITATIVE RESEARCH  
No qualitative research was included in this systematic review.  
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4 Findings 
 
4.1  OVERVIEW 
In Medline, 3,791 studies have been found using the searches with combined 
keywords. All different searching strategies together yielded 459 references to be 
retained for further examination; 68 are reviews, 220 have been rejected as being 
out of the scope of the present review (of these, 168 are available as full text 
versions), and 171 have been retained as being of interest (of these, 152 are available 
as full text). Among the 171 references retained, there are cases where several 
articles refer to a same study, while not necessarily reporting the same results. Sixty-
six studies have been coded. 46 of these either fulfil criteria of Sherman 4 or higher 
or are pre-post comparisons or population studies and have therefore been included 
in the present review.  
 
4.2  EFFECTS OF HEROIN SUBSTITUTION TREATMENT 
Among the coded eligible studies, 6 concern Heroin substitution programs, and 5 
are randomized controlled trials (RCTs). In four of the RCTs, the control group 
undergoes methadone maintenance (Dijkgraaf, 2005; Hartnoll et al., 1980; 
Löbmann et al., 2008; March et al., 2006), while in one (Perneger, 1998) the control 
group undergoes any conventional treatment (mostly Methadone maintenance 
treatment, MMT). A general description of these studies is available in the appendix, 
Table A1. One study is an intake-follow up investigation of the efficacy of Heroin 
(Killias et al., 1999). It was excluded from the models shown below. The effect sizes 
retained for these studies as well as the Random- and Fixed effects model effect sizes 
are reported in Table 1 below.  
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Table 1: Studies where treatment group receives Heroin maintenance and the control 
group either methadone or another standard treatment.  
First author Year Outcome OR CI low CI high p 
Dijkgraaf 2005 Arrest / property 
crime 
1.33 0.94 1.88 0.11 
Perneger 1998 Charged/any 
offense 
33.52 5.52 203.6 0.0001 
Hartnoll 1980 Arrest/any offense 2.37 1.08 5.22 0.03 
March 2006 Commission / any 
offense 
3.64 1.29 10.31 0.015 
Löbmann 2008 Charged / theft 1.43 0.79 2.59 0.24 
Fixed effects   1.65 1.27 2.16 0.0002 
Random effects   2.44 1.27 4.69 0.0072 
Killias 1999 Conviction / any 
offense 
6.58 4.46 9.69 <0.0001 
Notes: (1) The first five studies are RCTs and have been included in the model, while 
the last one is a pre-post study and that was excluded from the model. 
(2) An odds ratio >1.0 stands for a reduction in offending after treatment. 
(3) p is based on z-tests. 
 
Figure 1: Forest plot1 for the comparison described in table 1. The size of the boxes is 
proportional to the weight of the study in the summary measures. The confidence interval 
for the study by Perneger et al (2008) has been cut for representation (arrow). 
Dijkgraaf (2005)
Perneger (1998)
Hartnoll (1980)
March (2006)
Löbmann (2008)
Fixed Effects
Random Effects
 1 10 50
 
 
The standard deviation for all effects is 14.04; none of the studies was therefore 
winsorized. However, the study by Perneger (1998) includes 21 subjects in control 
group, and 27 in the treatment group; also, the confidence interval for this odds 
ratio is [5.52;203.6] and therefore, effects observed are very variable, certainly due 
to (1) the heterogeneous control group and (2) a small sample size. The Killias et al. 
                                                        
1 Forest plots have been constructed using R (www.r-project.org). 
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(1999) study may have a higher effect size because subjects in the Swiss heroin trial 
were selected for treatment considering particularly their high criminal involvement. 
 
The hypothesis of homogeneity is here rejected. If Perneger (1998) is not included in 
the analysis, due to the different treatment of the control group with respect to all 
other included studies, homogeneity is accepted. The Fixed effects mean effect size is 
then 1.55 [1.18; 2.02] (p=0.0015). Here, a significant decrease in the criminality 
measures is, therefore, present for Heroin rather than Methadone maintenance.  
 
4.3  EFFECTS OF BUPRENORPHINE SUBSTITUTION 
TREATMENT 
For the effect of Buprenorphine on criminal behaviour, 4 studies have been found. 3 
of these are RCTs. In two, the control group is in MMT (Harris et al., 2005; Magura 
et al., 2008, while in the third (Krook, 2002), the control group receives a placebo 
only. The individual and overall effects are shown in Table 2 below, while general 
descriptors of the studies are presented in the Appendix (Table A2). The fourth 
study (Kakko et al., 2003) is a randomized controlled trial as well, but the measure 
of criminality is only given for the treatment group in pre-post form.  
Table 2: Studies where treatment group receives Buprenorphine maintenance. The first 3 
are RCTs, while in the last the crime measure is only given in a pre-post form. 
First author Year Outcome OR CI low CI high p 
Harris 2005 Cost of crime / any 
offense 
5.74 3.03 10.86 <0.0001 
Krook 2002 Commission / any 
offense 
3.88 0.92 16.40 0.07 
Magura 2008 Arrest / any 
offense 
1.01 0.46 2.22 0.99 
Fixed effects   2.98 1.86 4.77 <0.0001 
Random effects   2.78 0.81 9.53 0.10 
Kakko 2003 Commission / any 
offense 
2.41 077 7.53 0.13 
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Figure 2: Forest plot for the comparison described in table 2. The size of the boxes is 
proportional to the weight of the study in the summary measures. 
Harris (2005)
Krook (2002)
Magura (2008)
Fixed effects
Random effects
 0.4  1.0 10.0 20.0
 
 
The hypothesis of homogeneity is refuted (Q test p=0.0033), and when the study 
with a differing control group (Krook et al., 2002) is excluded, this remains so (Q 
test p=0.0008). Overall, there is therefore no significant reduction in criminality 
when Buprenorphine instead of Methadone is used, although the effects have a 
tendency to be positive with Buprenorphine with respect to Methadone (or Placebo).  
 
4.4  METHADONE MAINTENANCE TREATMENT (MMT) 
For methadone maintenance, 41 studies have been found and coded; 2 of these are 
population studies, 11 are quasi-experimental studies (but 8 are Sherman 2 or 3 and 
have therefore been excluded, since a large number of studies have been found), 21 
are pre-post studies and 7 RCTs. The included studies are 7 RCTs and 3 quasi-
experimental studies. Among the RCTs, the control groups differ widely: three are 
waiting-list controls (Dole et al., 1969; Schwartz et al., 2007; Yancovitz et al., 1991), 
in one the control group receives a placebo (R. Newman et al., 1979), in one the 
control group receives counselling (Kinlock, 2008), in one the control group receives 
detoxification (Sees et al., 2000), and in one the control is treatment community 
(Bale et al., 1980). Among the quasi experimental studies, two controls are 
detoxification (Daley, 2000; Haglund et al., 1978) and one residential treatment 
(Teesson, 2006). A general description of these studies is given in the Appendix, 
Table A3. 
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Table 3: Studies fulfilling criteria of Sherman 4 or 5 where treatment group receives 
Methadone maintenance vs. control group with no substitution treatment. 
First author Year Outcome OR CI low CI high p 
Daley 2000 Cost of crime / any 
offence 
0.83 0.29 2.34 0.72 
Teesson 2006 Commission / any 
offence 
1.16 0.60 2.24 0.65 
Haglund 1987 Arrest / any offence 0.39 0.12 1.29 0.12 
Kinlock 2008 Incarceration / any 
offence 
2.73 1.12 6.67 .0.03 
Dole 1969 Incarceration / any 
offence 
45 4.04 500.71 0.002 
Bale 1980 Arrest / any offence 0.88 0.48 1.61 0.68 
Newman 1979 Conviction / any 
offence 
2.29 0.97 5.4 0.06 
Schwartz 2007 Illegal income / any 
offence 
1.18 0.78 1.77 0.44 
Yankowitz 1991 Incarceration/ any 
offence 
0.49 0.04 5.43 0.56 
Sees 2000 ASI legal / any 
offence 
2.47 1.31 4.63 0.01 
Fixed effects   1.34 1.06 1.70 0.01 
Random effects   1.40 0.91 2.16 0.12 
Figure 3: Forest plot for the comparison described in table 3. The size of the boxes is 
proportional to the weight of the study in the summary measures. The confidence intervals 
of Dole (1969) and Yankovitz (1991) are cut for the representation (arrows). 
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Again, homogeneity analysis refutes the hypothesis of homogeneity (p=0.0047). The 
random effects model does not indicate a significant effect of methadone 
maintenance with respect to these control groups; the mean effect measure is, 
however, in favour of Methadone maintenance.  
 
When groups are analysed separately by control groups, the between group 
variability is not significant. Also, homogeneity is not rejected for the detoxification 
(p=0.35) and counselling/residential treatment / treatment community (TC) control 
groups (p=0.63). Detailed results are given in table 4.  
Table 4: Effects on criminal behaviour for Methadone maintenance by type of treatment 
offered to the control group. Studies included fulfil Sherman 4 or 5.  
Control  Nb of studies Mean ES  CI ES low  CI ES high  p  
Detoxificationa 3 1.41 0.86 2.31 0.17 
Waiting listb 3 2.58 0.29 22.8 0.39 
Resid. / TC / 
Counsel. a 
3 1.22 0.82 1.82 0.32 
Placebo a 1 2.29 0.97 5.4 0.06 
Effect sizes indicated are based on a a fixed effects model and b a random effects 
model. P is based on z-tests. 
Figure 4: Forest plot for the comparison described in table 4. The size of the boxes is 
proportional to the inverse variance of the odds ratio in every group of studies. 
Detoxification
Waiting list
Resid. / TC / Counsel.
Placebo
 0.29  1.00 10.00
 
Therefore, Methadone maintenance has no significantly better effect on criminality 
than any of these control treatments. Also, a non-significant but positive effect of 
Methadone maintenance over all other control conditions is detected.  
 
In table 5, the results for the pre-post (or rather, during) studies using methadone 
are reported. One of these studies is a randomized controlled trial of oral versus 
intravenous methadone delivery (Strang et al., 2000); only the pre-post results of 
the oral methadone group are presented here, since it was decided to compare 
different substances of substitution rather than dosages or ways of administration. 
Effect sizes (log odds ratios) have been computed by comparing pre-treatment levels 
of offending and average individual offending rates during maintenance treatment. 
This explains the sometimes very large odds ratios obtained. Also, the maximum 
effect size obtained (1081) is observed in a study with only 24 participants.  
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Table 5: Pre-post studies of Methadone maintenance 
First author Year Outcome OR CI low CI high p 
Rothbard  1999 Arrest /Any offence 0.74 0.62 0.89 0.0017 
Déglon 1994 Days incarcerated / any 
offence 
11.17 4.05 30.80 <0.0001 
Cushman 1974 Arrest / property offence 8.18 3.36 19.92 <0.0001 
Dole 1968 Conviction / any offence 170.44 118.67 244.82 <0.0001 
Bali 1988 Commission / any 
offence 
26.68 18.72 38 <0.0001 
Schut 1975 Arrest / violent offence 14.79 4.81 45.43 <0.0001 
Grellaa  1995 Commission / theft 0.69 0.32 1.49 0.34 
Grellab  1995 Commission / theft 1.69 0.98 2.92 0.06 
Grellac  1995 Commission / theft 0.85 0.38 1.87 0.68 
Cushman 1976 Arrest / any offence 8.63 5.72 13.01 <0.0001 
Newman 1973 Arrest / any offence 6.14 3.94 9.57 <0.0001 
Langrod 1973 Arrest / any offence 26.8 17.72 40.64 <0.0001 
Keen 2000 Conviction and caution / 
any offence 
1.67 0.86 3.27 0.13 
Keen 2003 Commission / property 
crime 
18.25 5.41 61.64 <0.0001 
Walger 1989 Incarceration / any 
offence 
1081 33.34 35041 <0.0001 
Strang 2000 Commission / property 
offences 
1.57 0.31 7.85 0.55 
Simpson 1997 Commission or 
incarceration / any 
offence 
5.02 2.81 8.96 <0.0001 
Sheerin 2004 Commission / any 
offence 
148.50 18.56 1188 <0.0001 
Perreault 2007 Earning from illegal 
activity 
2.53 1.02 6.27 0.04 
Kott 2001 Arrest / any offence 4.44 1.58 12.48 0.0047 
Bates 1996 Conviction / any offence 2.56 0.91 7.17 0.07 
Fixed effects   4.37 3.94 4.86 <0.0001 
Random effects   6.92 3.04 15.77 <0.0001 
a Results for white b for African-American and c for Latino women 
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Figure 5: Forest plot for the comparison described in table 5. The size of the boxes is 
proportional to the weight of the study in the summary measures. The confidence intervals 
for Walger (1989) and Sheerin (2004) have been cut for representation (arrows). 
Rothbard (1999)
 Déglon (1994)
 Cushman (1974)
 Dole (1968)
 Bali (1988)
 Schut (1975)
 Grellaa (1995)
 Grellab (1995)
 Grellac (1995)
 Cushman (1976)
 Newman (1976)
 Langrod (1973)
 Keen (2000)
 Keen (2003)
 Walger (1989)
 Strang (2000)
 Simpson (1997)
 Sheerin (2004)
 Perreault (2007)
 Kott (2001)
 Bates (1996)
Fixed effects
Random effects
2e-01 1e+00 1e+01 1e+02 1e+03
The hypothesis of homogeneity is again rejected. Here, a beneficial effect of 
methadone maintenance is observed with respect to baseline. This in no way 
contradicts results obtained above, where Methadone is not significantly more 
effective than other substances in reducing criminality; indeed, these pre-post 
studies only show decreasing criminality during treatment, not whether this is a 
comparatively effective treatment or even whether the effect is due to being in 
treatment or to the passage of time.  
 
As for the two population studies, only general results will be reported here since 
none includes comparison macro units. The first one, carried out by Niveau et al 
(2002) reports a significant positive correlation of crime known to the police in 
Geneva with the number of addicts in MMT (with r of 0.71 [0.73; 0.68]). In a 
reaction, however, Aebi (2001) observed that the overall population of drug addicts 
needs to be taken into account in such a trend analysis. When this is done, the effect 
turns in favour of MMT with a significant r of -0.19 [-0.14;-0.24]. In the second 
population study (Maddux & Desmond, 1979), a negative correlation is obtained, 
with an r of -0.93 [-1.03, -0.84].  
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4.5  EFFECTS OF NALTREXONE TREATMENT 
While Naltrexone is not a substitution treatment (rather the prescription of an 
inhibiting substance) it is included; effects are shown in table 6. Two RCTs have 
been found, one contrasting Naltrexone with counselling (Cornish et al., 1997) and 
one with behaviour therapy (Rawson, 1979); also, one pre-post trial is shown in table 
6 (De Jong et al., 2007). The descriptors of the studies included in the meta-analysis 
are given in the Appendix, Table A4. 
Table 6: Effects of Naltrexone on criminal behaviour 
First author Year Outcome OR CI low CI high p 
Cornish 1997 Incarceration / any offense ( + 
probation violation) 
3.61 1.06 12.35 0.04 
Rawson 1979 Incarceration / any offense 1.66 1.39 1.99 <0.0001 
Fixed effects   3.21 1.23 8.31 0.02 
Random effects   3.21 1.23 8.31 0.02 
De Jong 2007 EuropASI justice / police 2.67 0.59 12.09 0.20 
Figure 6: Forest plot for the comparison described in table 6. The size of the boxes is 
proportional to the weight of the study in the summary measures.  
Cornish (1997)
Rawson (1979)
Fixed effects
 1 10 15
 
Here, homogeneity is not rejected by the test; Naltrexone is here shown to have a 
significant and beneficial effect on criminal behaviour with respect to psychological 
interventions.  
 
4.6  EFFECTS OF OTHER SUBSTITUTION TREATMENTS 
Finally, two RCTs have been found that use other replacement therapies: one where 
Levo-alpha-acetylmethadone (LAAM) is compared to MMT (Eissenberg et al., 1997) 
and one where MMT is compared to Dihydrocodeine (Robertson et al., 2006). In the 
first case, the effect favours LAAM; the effect size is 1.93 [0.16, 22.31] and the effect 
is not significant. However, very serious side-effects (torsade de pointes) have been 
observed with this substitution drug that is, for this reason, unavailable in Europe. 
In the second case, the effect size is 0.96 [0.39; 2.37] and is not significant either.  
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5 Discussion 
Two systematic reviews of substitution programs have been carried out to be 
included in the Cochrane database of systematic reviews: Ferri et al (2006) and 
Mattick et al (2006). While these reviews do not focus on delinquency as an 
outcome measure, a comparison of results with the present report seems relevant. In 
Ferri et al (2006), 4 trials comparing methadone maintenance to Heroin 
maintenance are included. One study showed a reduction in the risk of being 
charged when on Heroin maintenance; this in line with the results obtained here. 
Also, two studies considered criminal offending and social functioning in a multi 
domain outcome measure, and again, heroin plus methadone maintenance yields 
better results than methadone alone. Again, this is in line with the results obtained 
here, i.e. heroin maintenance reduced criminality more than other maintenance 
treatments.  
 
In Mattick et al (2006), three studies comparing methadone maintenance to no 
opioid replacement therapy with respect to their effect on criminal behaviour are 
included. The results obtained are similar to the results obtained here in two 
respects: firstly, the effect of methadone maintenance seems to reduce criminal 
behaviour more than the alternatives, and secondly, this effect is not significant.  
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6 Conclusion 
Heroin maintenance reduces crime significantly more than Methadone 
maintenance. Methadone maintenance itself does not have a significant effect on 
criminal behaviour; in particular with respect to two detoxification and one 
treatment community program, the effect is even negative. While Methadone 
maintenance is, with respect to reductions in offending, not to be the preferred 
treatment, it was found to be promising in comparison to detoxification, treatment 
community, counselling and residential treatment, placebo and waiting list controls. 
These reductions are not significant, while very large (and significant) reductions in 
criminal behaviour are observed during Methadone maintenance with respect to 
pre-treatment levels.  
 
Buprenorphine does not significantly reduce criminal behaviour, although effects 
are strictly positive, be it with respect to Methadone or a placebo.  
 
Finally, a quite different treatment has been evaluated here as well: Naltrexone. This 
treatment reduces criminality significantly more than behaviour therapy or 
counselling.  
 
Overall, crime reduction among addicts, though important in itself, will probably not 
be the only goal to give attention to. This review does not address other (possibly 
different) effects of substitution therapy on other goals, such as promoting 
abstinence or improving health. 
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7 Plans for updating the Review 
This review will be updated every five years to include new treatment studies 
published in any language. The primary authors will take the lead in this update.  
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11 Appendix: Tables of General Study Descriptors 
Table A1 : General description of studies included in the meta-analysis where the treatment group receives Heroin  
First 
author 
Year Outcome Measure nexp ncontrol Outcomeexp Outcomecontrol Duration 
Treatment 
experimental 
Treatment control 
Dijkgraaf 2005 
arrests / 
property crime1 
Self-report 1932 2372 37(134) 65(207) 12 months 
Methadone + 
Heroin 
Methadone 
Perneger 1998 
Charged/any 
offense 
Self-report 27 243 20/54 7/124 196 days Heroin 
Standard (many 
methadone) 
Hartnoll 1980 
Arrest/any 
offense 
Self-report (checked 
against official 
records if possible) 
42 46 52% 72% 12 months Heroin Methadone 
March 2006 
Commission / 
any offense 
Nb days involved in 
criminal activity ; Self-
report 
31(27) 31(23) 12(13.7) 5 3.8(7.6) 5 9 months 
Methadone + 
Heroin 
Methadone 
Löbmann 2008 Charged / theft Official data 419 406 12.4%/9.5%2 13.3%/12.4%6 12 months Heroin Methadone 
1 mean (sd) for 100 participants 
2 initial numbers; 135 (70%, experimental) and 204 (86%, control) patients completed 12 months of treatment 
3 In the control group, only data for 21 participants is available and has been used.  
4 In the 6 months before the trial/after 196 days of trial (mean) 
5 diminution of mean number of days of crime with respect to t0 
6 In the month before beginning treatment/after 12 months of treatment 
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Table A2: General description of studies included in the meta-analysis where the treatment group receives Buprenorphine  
First 
author 
Year Outcome Measure nexp ncontrol Outcomeexp Outcomecontrol Duration 
Treatment 
experimental 
Treatment control 
Harris 2005 
Cost of crime / 
any offense 
Self-report (and cost 
attributions) 
73 66 6265(2028) 13223(10209) 
12 
months 
Buprenorphine Methadone 
Krook 2002 
Commission / 
any offense 
Self-report 51 48 96.1%1 99%%1 3 months Buprenorphine Placebo 
Magura 2008 
Arrest / any 
offense 
Self-report 43 38 0.69(0.95)2 0.71(0.77)2 
3 months 
post-
release 
Buprenorphine Methadone 
1 The numbers given in the research are « no criminal activities » (3.9% and 1.0% 
2 mean number of arrests(sd) 
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Table A3: General description of studies included in the meta-analysis where the treatment group receives Methadone  
First 
author 
Year Outcome Measure nexp ncontrol Outcomeexp Outcomecontrol Duration 
Treatment 
experimental 
Treatment control 
Daley 2000 
Cost of 
crime / any 
offence 
Self-report (& cost 
estimates) 
54 183 
1584.99 
(15321.54)1 
- 202 days Methadone Detoxification 
Teesson 2006 
Commission 
/ any offence 
Self-report 227 141 45%/19% 61%/27% 
12 
months 
Methadone 
Residential 
rehabilitation 
Haglund 1978 
Arrest / any 
offence 
Self-report 
corroborated by 
official police records 
130 62 
39.2%/20.8
% 
35.5%/ 
24 
months 
Methadone Detoxification 
Kinlock 2008 
Incarceration 
/ any offence 
Self-report 68 63 13% 29% 6 months 
Counselling + 
methadone 
Counselling 
Dole 1969 
Incarceration 
/ any offence 
Official sources 12 16 25% 93.8% 
7-10 
months 
Methadone Waiting list 
Bale 1980 
Arrest / any 
offence 
Self-report 59 150 49.2% 46% 
12 
months 
Methadone 
Treatment 
community 
Newman 1979 
Conviction / 
any offence 
Unknown 50 50 1.42 3.22 
36 
months 
Methadone Placebo 
Schwartz 2007 
Illegal 
income / any 
offence 
Self-report 199 120 4163 3363 
2-10 
months 
Methadone Waiting list 
Yankowitz 1991 
Incarceration
/ any offence 
Known status at end 
of study 
149 152 1.4% 0.7% 
16 
months 
Methadone Waiting list 
Sees 2000 
ASI legal / 
any offence 
Self-report 77 57 0.05(0.13)4 0.13(0.193)4 
12 
months 
Methadone Detoxification 
1Regression coefficient 
2Conviction rate per 100 man-months of enrolment 
3Pre-post difference of illegal income 
4mean(sd) 
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Table A4: General description of studies included in the meta-analysis where the treatment group receives Naltrexone 
 
First 
author 
Year Outcome Measure nexp ncontrol Outcomeexp Outcomecontrol Duration 
Treatment 
experimental 
Treatment 
control 
Cornish 1997 
Incarceration 
/ any offense 
( + probation 
violation) 
Return to prison 
(official source) 
34 17 26% 56% 6 months 
Counselling 
&Naltrexone 
Counsellin
g 
Rawson 1979 
Incarceration 
/ any offense 
Official source 20 15 20% 40% 12 months 
Behaviour 
therapy & 
Naltrexone 
Behaviour 
therapy 
 
